These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4605362)

  • 21. Laetrilomania--again.
    Relman AS
    N Engl J Med; 1978 Jan; 298(4):215-6. PubMed ID: 339088
    [No Abstract]   [Full Text] [Related]  

  • 22. Sham surgery is used to test effectiveness of novel operations.
    Johannes L
    Wall St J (East Ed); 1998 Dec; ():A1. PubMed ID: 11647570
    [No Abstract]   [Full Text] [Related]  

  • 23. Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solution.
    Sobel BE
    Coron Artery Dis; 1999 Jul; 10(5):339-41. PubMed ID: 10421975
    [No Abstract]   [Full Text] [Related]  

  • 24. Gender differences in research.
    Rogers B
    AAOHN J; 1994 Jan; 42(1):30-2. PubMed ID: 8147983
    [No Abstract]   [Full Text] [Related]  

  • 25. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract]   [Full Text] [Related]  

  • 26. Molindone: a crossover evaluation of capsule and tablet formulations in severely ill schizophrenic patients.
    Gallant DM; Bishop MP; Steele CA; Bishop G; Guerrero-Figueroa R
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):915-8. PubMed ID: 4203575
    [No Abstract]   [Full Text] [Related]  

  • 27. The design of drug trials with neurotic patients.
    Kellner R
    Behav Neuropsychiatry; 1970; 2(1):12-9. PubMed ID: 4913956
    [No Abstract]   [Full Text] [Related]  

  • 28. Suicide and antidepressant treatment.
    Hirschfeld RM
    Arch Gen Psychiatry; 2000 Apr; 57(4):325-6. PubMed ID: 10768691
    [No Abstract]   [Full Text] [Related]  

  • 29. From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireus.
    LaMontagne JR; Galasso GJ
    J Infect Dis; 1978 Dec; 138(6):928-31. PubMed ID: 368266
    [No Abstract]   [Full Text] [Related]  

  • 30. The placebo control in clinical trials (a view from the FDA).
    Leber P
    Psychopharmacol Bull; 1986; 22(1):30-2. PubMed ID: 3726077
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of tranquilizing and antidepressant drugs.
    Davis JM
    Arch Gen Psychiatry; 1965 Dec; 13(6):552-72. PubMed ID: 5320622
    [No Abstract]   [Full Text] [Related]  

  • 32. Investigational new drug regulations.
    AORN J; 1988 Jun; 47(6):1473. PubMed ID: 3389785
    [No Abstract]   [Full Text] [Related]  

  • 33. US health agencies at odds over trial deaths.
    Macilwain C
    Nature; 1994 Jun; 369(6480):433. PubMed ID: 8202125
    [No Abstract]   [Full Text] [Related]  

  • 34. Polypharmacy in psychiatry: empiricism, efficacy, and rationale.
    Merlis S; Beyel V; Fiorentino D; Fracchia J; Sheppard C
    Curr Psychiatr Ther; 1972; 12():89-97. PubMed ID: 4555860
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene therapy's trials.
    Nature; 2000 Jun; 405(6787):599. PubMed ID: 10864286
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory concerns at various phases of drug development.
    Aurecchia S; Orloff D; Sobel S
    Am J Cardiol; 1998 Apr; 81(8A):2F-4F. PubMed ID: 9604895
    [No Abstract]   [Full Text] [Related]  

  • 37. When do the federal regulations allow placebo-controlled trials in children?
    Miller FG; Wendler D; Wilfond B
    J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug development process for a product with a primary pediatric indication.
    Allen AJ; Michelson D
    J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory issues for Data and Safety Monitoring Committees.
    Fisher L; Klibaner M
    Am Heart J; 2001 Apr; 141(4):536-41. PubMed ID: 11275916
    [No Abstract]   [Full Text] [Related]  

  • 40. The assessment of adverse drug reactions in clinical trials.
    Petrie WM; Levine J
    Int Pharmacopsychiatry; 1978; 13(4):209-16. PubMed ID: 730486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.